Vitacost.com (VITC) 10-Q 8 May 14 2014 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2014	2-May-14
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'VITACOST.COM, INC.	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	34,053,791
Amendment Flag	'false	'
Entity Central Index Key	'0001401688	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Accelerated Filer	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	31-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current Assets	'	'
Cash and cash equivalents	$29,092	$24,799
Accounts receivable, net	2,957	1,486
Inventory	35,653	37,143
Prepaid expenses	1,159	902
Other current assets	490	567
Total current assets	69,351	64,897
Property and equipment, net	29,315	30,288
Other assets	3,256	3,192
Total assets	101,922	98,377
Current Liabilities	'	'
Accounts payable	34,475	29,357
Deferred revenue	5,135	4,634
Accrued expenses	6,760	6,326
Total current liabilities	46,370	40,317
Deferred tax liability	415	402
Total liabilities	46,785	40,719
Stockholders' Equity	'	'
Additional paid-in capital	115,048	113,658
Warrants	4,347	4,347
Accumulated deficit	-64,258	-60,347
Total stockholders' equity	55,137	57,658
Total liabilities and stockholders' equity	$101,922	$98,377

Consolidated_Balance_Sheets_Un1

Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, except Per Share data, unless otherwise specified
Preferred stock par value (in Dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	25,000	25,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, shares authorized	100,000	100,000
Common stock, shares issued	34,054	34,050
Common stock, shares outstanding	34,054	34,050

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Loss (Unaudited) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Net sales	$104,830	$97,756
Cost of goods sold	81,712	75,127
Gross profit	23,118	22,629
Operating expenses:	'	'
Fulfillment	9,264	8,915
Sales and marketing	8,700	8,417
General and administrative	9,075	8,303
	27,039	25,635
Operating loss	-3,921	-3,006
Other income	23	20
Loss before income taxes	-3,898	-2,986
Income tax expense	-13	-13
Net loss	-3,911	-2,999
Basic and diluted per share information:	'	'
Net loss attributable to common stockholders (in Dollars per share)	($0.11)	($0.09)
Weighted average shares outstanding (in Shares)	34,051	33,519
Comprehensive loss	($3,911)	($2,999)

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholdersb Equity (Unaudited) (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Warrant [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Total
In Thousands		USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Balance at Dec. 31, 2013	'	$113,658	$4,347	($60,347)	$57,658	$57,658
Balance (in Shares) at Dec. 31, 2013	34,050	'	'	'	'	'
Net loss	'	'	'	-3,911	-3,911	-3,911
Stock options exercised	'	24	'	'	24	'
Stock options exercised (in Shares)	4	'	'	'	'	4
Stock-based compensation expense	'	840	'	'	840	'
RSUs issued in lieu of cash for 2013 bonus	'	526	'	'	526	'
Balance at Mar. 31, 2014	'	$115,048	$4,347	($64,258)	$55,137	$55,137
Balance (in Shares) at Mar. 31, 2014	34,054	'	'	'	'	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash Flows From Operating Activities	'	'
Net loss	($3,911)	($2,999)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Depreciation and amortization	1,704	1,655
Stock-based compensation expense	840	775
Deferred income taxes	13	13
Loss on disposition of property and equipment and other assets	'	3
(Increase) decrease in:	'	'
Accounts receivable	-1,471	-319
Other current assets	77	804
Inventory	1,490	-8,041
Prepaid expenses	-257	-275
Other assets	-139	10
Increase (decrease) in:	'	'
Accounts payable	5,083	6,975
Deferred revenue	501	-612
Accrued expenses	862	999
Net cash provided by (used in) operating activities	4,792	-1,012
Cash Flows From Investing Activities	'	'
Proceeds from disposition of property and equipment	'	2
Payments for the purchase of property and equipment	-523	-1,469
Increase in restricted cash	'	-250
Net cash used in investing activities	-523	-1,717
Cash Flows From Financing Activities	'	'
Proceeds from the exercise of stock options	24	538
Net cash provided by financing activities	24	538
Net increase (decrease) in cash and cash equivalents	4,293	-2,191
Cash and cash equivalents:	'	'
Beginning of year	24,799	32,152
End of period	29,092	29,961
Supplemental Schedule of Noncash Activities	'	'
Equipment purchased not yet paid	132	'
Restricted Stock Units (RSUs) [Member]	'	'
Supplemental Schedule of Noncash Activities	'	'
RSUs issued in lieu of cash for 2013 bonus	$526	'

Note_1_Nature_of_Business_Sign

Note 1 - Nature of Business, Significant Accounting Policies and Recent Accounting Guidance	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	'
	1.  Nature of Business, Significant Accounting Policies and Recent Accounting Guidance
	Nature of Business
	Vitacost.com, Inc.  (“Vitacost” or the “Company”) is a leading online retailer of healthy living products, including dietary supplements such as vitamins, minerals, herbs and other botanicals, as well as cosmetics, natural personal care products, pet products, sports nutrition and health foods. Vitacost was incorporated in 1994 and began its online retail activity in 1999. Vitacost sells a proprietary line of healthy living products as well as a wide selection of other manufacturers’ brand-name goods.  The Company ships products from two distribution centers located in Lexington, North Carolina and Las Vegas, Nevada.
	Basis of presentation
	The accompanying unaudited consolidated financial statements of Vitacost as of March 31, 2014, and for the three months ended March 31, 2014 and 2013, have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information along with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles (“GAAP”) for annual financial statements. In management’s opinion, Vitacost has made all adjustments (consisting of normal, recurring and non-recurring adjustments) during the quarter that were considered necessary for the fair statement of the financial position and operating results of the Company. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect reported amounts in the financial statements and accompanying notes. Actual results could differ from those estimates. In addition, the results of operations for the three months ended March 31, 2014 are not necessarily indicative of the results for the entire fiscal year ending December 31, 2014, or for any other period. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes, together with management’s discussion and analysis of financial position and results of operations, contained in Vitacost’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013 (the “Form 10-K”).
	Significant Accounting Policies
	Principles of consolidation:
	The consolidated financial statements include the accounts of Vitacost and its wholly-owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation.
	Reclassifications:
	Reclassifications on the 2013 consolidated statement of cash flows have been made to conform to the 2014 presentation.
	Earnings per share:
	The Company computed earnings per share by dividing its net loss by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by giving effect to all potentially dilutive common shares, including stock options, warrants and restricted stock units (“RSUs”). The following table reconciles basic weighted-average shares outstanding to diluted weighted-average shares outstanding for the three months ended March 31, 2014 and 2013:
			Three Months Ended
			March 31,
			2014		2013
			(In thousands)
	Weighted-average shares outstanding - basic			34,051		33,519
	Effect of dilutive securities			-		-
	Weighted-average shares outstanding - diluted			34,051		33,519
	For the periods where the Company reported losses, all common stock equivalents are excluded from the computation of diluted earnings per share, since the result would be antidilutive. Securities that were not included in the calculation of diluted earnings per share because to do so would have been antidilutive for the periods presented are as follows:
			Three Months Ended
			March 31,
			2014		2013
			(In thousands)
	Stock options			3,013		2,682
	Warrants			1,681		1,681
	Restricted stock units			277		-
	Total antidilutive common stock equivalents excluded from diluted earnings per share			4,971		4,363
	Restricted cash:
	Restricted cash consists of cash pledged as collateral to a vendor.
	Fair value of financial instruments:
	Existing accounting guidance defines fair value, establishes a framework and gives guidance regarding the methods used for measuring fair value, and requires disclosures about fair value measurements. The guidance applies to all assets and liabilities that are being measured and reported on a fair value basis. It requires disclosure that establishes a framework for measuring fair value in GAAP and about fair value measurements. This guidance enables the reader of the financial statements to assess the inputs used to develop those measurements by establishing a hierarchy for ranking the quality and reliability of the information used to determine fair value. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:
		Level 1:	Quoted market prices in active markets for identical assets or liabilities.
		Level 2:	Observable market based inputs or unobservable inputs that are corroborated by market data.
		Level 3:	Unobservable inputs that are not corroborated by market data.
	The carrying amounts of other financial instruments, including cash, cash equivalents, accounts receivable, other receivables and accounts payable approximate fair value due to the short maturity of these instruments. Cash and cash equivalents are a Level 1 instrument within the fair value hierarchy.
	Concentration of credit risk:
	The Company’s cash and cash equivalents were held by one major financial institution and for certain accounts exceed federally insured limits. These cash and cash equivalent balances could be impacted if this financial institution fails or is subjected to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to its cash and cash equivalents.
	Recently Adopted and Recently Issued Accounting Guidance
	The Company did not adopt any accounting guidance nor was there any new accounting guidance issued during the period that had or would have had a material impact on the Company’s consolidated financial statements.

Note_2_Inventory

Note 2 - Inventory	3 Months Ended
	Mar. 31, 2014
Inventory Disclosure [Abstract]	'
Inventory Disclosure [Text Block]	'
	2. Inventory
	Inventory consisted of the following as of March 31, 2014 and December 31, 2013:
		March 31,		December 31,
		2014		2013
		(In thousands)
	Bulk and other	$	713	$	872
	Finished goods		34,940		36,271
		$	35,653	$	37,143

Note_3_Property_and_Equipment

Note 3 - Property and Equipment	3 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	3. Property and Equipment
	Property and equipment consisted of the following as of March 31, 2014 and December 31, 2013:
		March 31,			December 31,
		2014			2013
		(In thousands)
	Buildings and building improvements	$	12,863		$	12,863
	Furniture, fixtures and equipment		26,392			26,917
	Computers		4,973			5,076
	Software		9,442			9,335
	Leasehold improvements		2,827			2,823
	Land		460			460
			56,957			57,474
	Less accumulated depreciation		(28,618	)		(27,921	)
			28,339			29,553
	Construction-in-progress		976			735
		$	29,315		$	30,288

Note_4_Other_Assets

Note 4 - Other Assets	3 Months Ended
	Mar. 31, 2014
Disclosure Text Block Supplement [Abstract]	'
Other Assets Disclosure [Text Block]	'
	4. Other Assets
	Other assets consisted of the following as of March 31, 2014 and December 31, 2013:
		March 31,		December 31,
		2014		2013
		(In thousands)
	Goodwill	$	2,200	$	2,200
	Intangible assets, net		525		600
	Deposits		281		142
	Restricted cash		250		250
		$	3,256	$	3,192

Note_5_StockBased_Compensation

Note 5 - Stock-Based Compensation	3 Months Ended
	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
	5. Stock-Based Compensation
	A summary of the Company’s stock option activity for the three months ended March 31, 2014 and 2013 is as follows:
		2014					2013
					Weighted-					Weighted-
					Average					Average
					Exercise					Exercise
		Shares			Price		Shares			Price
		(In thousands except exercise price)
	Outstanding at beginning of period		4,980		$	7.01		5,209		$	6.4
	Granted		810			5.96		510			7.15
	Exercised		(4	)		6.61		(102	)		5.27
	Forfeited or expired		(81	)		7.29		(322	)		4.99
	Outstanding at period end		5,705		$	6.85		5,295		$	6.58
	Exercisable at period end		3,013		$	7		2,682		$	6.88
	As of March 31, 2014, there was approximately $7.4 million of total unrecognized compensation cost, net of estimated forfeitures, related to stock options granted under the Company’s stock incentive plans, which is expected to be recognized over a weighted average period of 3.76 years.
	RSUs are converted into shares of common stock upon vesting which is time based. These awards generally vest over a maximum five years. The cost of these awards is determined using the fair value of the Company’s common stock on the date of the grant and compensation expense is recognized over the vesting period.
	A summary of the Company’s restricted stock unit activity for the three months ended March 31, 2014 is as follows:
					Weighted-
					Average
		Number of			Grant Date
		Awards			Fair Value
	Outstanding at beginning of period		-		$	-
	Granted		276,900			5.77
	Vested		-			-
	Forfeited		-			-
	Outstanding at period end		276,900		$	5.77
	As of March 31, 2014, there was approximately $0.9 million of total unrecognized compensation cost, net of estimated forfeitures, related to RSUs granted under the Company’s stock incentive plan, which is expected to be recognized over the weighted-average period of 4.80 years.

Note_6_Contingencies

Note 6 - Contingencies	3 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	6.    Contingencies
	Sales or Other Taxes:
	A number of states have sought to impose sales or other tax collection obligations on online retailers. Certain states have imposed such a sales tax obligation on remote online retailers that use residents of that state to directly or indirectly refer potential customers, via a link on an internet website or other means, to the online retailer for a commission-based fee. There is still significant uncertainty as to whether or how existing laws governing these matters apply to Vitacost and how these laws will be interpreted for the Company and other online retailers. As a result, it is currently not possible to determine the ultimate outcome as to whether such potential obligations apply to the Company under its specific facts and circumstances. Because the Company does not believe that it is probable such potential obligations are applicable to its specific facts and circumstances, it has not accrued for such potential obligations as of March 31, 2014. The Company is also currently unable to estimate the amount of the loss, if any, should such potential obligations apply. The eventual outcome of a successful assertion by one or more states that the Company should collect sales or other taxes may be materially different from any provisions or disclosures the Company has previously made and could have a material adverse effect on the Company’s financial position, results of operations and cash flows.
	Other matters:
	In addition to the matters described above, the Company is involved in litigation and administrative proceedings primarily arising in the normal course of its business. In the opinion of the Company, its liability, if any, under any pending litigation or administrative proceedings would not materially affect its financial condition, results of operations or cash flows.

Note_7_Income_Taxes

Note 7 - Income Taxes	3 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	7. Income Taxes
	The Company evaluates its deferred tax assets on a regular basis to determine if valuation allowances are required. In its evaluation, the Company considers taxable loss carryback availability, expectations of sufficient future taxable income, trends in earnings, existence of taxable income in recent years, the future reversal of temporary differences and available tax planning strategies that could be implemented, if required.  Valuation allowances are established based on the consideration of all available evidence using a more likely than not standard.  Based on the Company’s evaluation, a valuation allowance of $1.3 million was established against its net deferred tax assets for the three months ended March 31, 2014. This amount was in addition to the $21.4 million valuation allowance that was recorded as of December 31, 2013.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	'
	Nature of Business
	Vitacost.com, Inc.  (“Vitacost” or the “Company”) is a leading online retailer of healthy living products, including dietary supplements such as vitamins, minerals, herbs and other botanicals, as well as cosmetics, natural personal care products, pet products, sports nutrition and health foods. Vitacost was incorporated in 1994 and began its online retail activity in 1999. Vitacost sells a proprietary line of healthy living products as well as a wide selection of other manufacturers’ brand-name goods.  The Company ships products from two distribution centers located in Lexington, North Carolina and Las Vegas, Nevada.
Consolidation, Policy [Policy Text Block]	'
	Principles of consolidation:
	The consolidated financial statements include the accounts of Vitacost and its wholly-owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation.
Earnings Per Share, Policy [Policy Text Block]	'
	Earnings per share:
	The Company computed earnings per share by dividing its net loss by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by giving effect to all potentially dilutive common shares, including stock options, warrants and restricted stock units (“RSUs”). The following table reconciles basic weighted-average shares outstanding to diluted weighted-average shares outstanding for the three months ended March 31, 2014 and 2013:
			Three Months Ended
			March 31,
			2014		2013
			(In thousands)
	Weighted-average shares outstanding - basic			34,051		33,519
	Effect of dilutive securities			-		-
	Weighted-average shares outstanding - diluted			34,051		33,519
	For the periods where the Company reported losses, all common stock equivalents are excluded from the computation of diluted earnings per share, since the result would be antidilutive. Securities that were not included in the calculation of diluted earnings per share because to do so would have been antidilutive for the periods presented are as follows:
			Three Months Ended
			March 31,
			2014		2013
			(In thousands)
	Stock options			3,013		2,682
	Warrants			1,681		1,681
	Restricted stock units			277		-
	Total antidilutive common stock equivalents excluded from diluted earnings per share			4,971		4,363
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]	'
	Restricted cash:
	Restricted cash consists of cash pledged as collateral to a vendor.
Fair Value of Financial Instruments, Policy [Policy Text Block]	'
	Fair value of financial instruments:
	Existing accounting guidance defines fair value, establishes a framework and gives guidance regarding the methods used for measuring fair value, and requires disclosures about fair value measurements. The guidance applies to all assets and liabilities that are being measured and reported on a fair value basis. It requires disclosure that establishes a framework for measuring fair value in GAAP and about fair value measurements. This guidance enables the reader of the financial statements to assess the inputs used to develop those measurements by establishing a hierarchy for ranking the quality and reliability of the information used to determine fair value. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:
		Level 1:	Quoted market prices in active markets for identical assets or liabilities.
		Level 2:	Observable market based inputs or unobservable inputs that are corroborated by market data.
		Level 3:	Unobservable inputs that are not corroborated by market data.
	The carrying amounts of other financial instruments, including cash, cash equivalents, accounts receivable, other receivables and accounts payable approximate fair value due to the short maturity of these instruments. Cash and cash equivalents are a Level 1 instrument within the fair value hierarchy.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	'
	Concentration of credit risk:
	The Company’s cash and cash equivalents were held by one major financial institution and for certain accounts exceed federally insured limits. These cash and cash equivalent balances could be impacted if this financial institution fails or is subjected to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to its cash and cash equivalents.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recently Adopted and Recently Issued Accounting Guidance
	The Company did not adopt any accounting guidance nor was there any new accounting guidance issued during the period that had or would have had a material impact on the Company’s consolidated financial statements.

Note_1_Nature_of_Business_Sign1

Note 1 - Nature of Business, Significant Accounting Policies and Recent Accounting Guidance (Tables)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Schedule of Weighted Average Number of Shares [Table Text Block]	'
		Three Months Ended
		March 31,
		2014		2013
		(In thousands)
	Weighted-average shares outstanding - basic		34,051		33,519
	Effect of dilutive securities		-		-
	Weighted-average shares outstanding - diluted		34,051		33,519
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'
		Three Months Ended
		March 31,
		2014		2013
		(In thousands)
	Stock options		3,013		2,682
	Warrants		1,681		1,681
	Restricted stock units		277		-
	Total antidilutive common stock equivalents excluded from diluted earnings per share		4,971		4,363

Note_2_Inventory_Tables

Note 2 - Inventory (Tables)	3 Months Ended
	Mar. 31, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventory, Current [Table Text Block]	'
		March 31,		December 31,
		2014		2013
		(In thousands)
	Bulk and other	$	713	$	872
	Finished goods		34,940		36,271
		$	35,653	$	37,143

Note_3_Property_and_Equipment_

Note 3 - Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Schedule Of Property Plant And Equipment [Table Text Block]	'
		March 31,			December 31,
		2014			2013
		(In thousands)
	Buildings and building improvements	$	12,863		$	12,863
	Furniture, fixtures and equipment		26,392			26,917
	Computers		4,973			5,076
	Software		9,442			9,335
	Leasehold improvements		2,827			2,823
	Land		460			460
			56,957			57,474
	Less accumulated depreciation		(28,618	)		(27,921	)
			28,339			29,553
	Construction-in-progress		976			735
		$	29,315		$	30,288

Note_4_Other_Assets_Tables

Note 4 - Other Assets (Tables)	3 Months Ended
	Mar. 31, 2014
Disclosure Text Block Supplement [Abstract]	'
Schedule of Other Assets, Noncurrent [Table Text Block]	'
		March 31,		December 31,
		2014		2013
		(In thousands)
	Goodwill	$	2,200	$	2,200
	Intangible assets, net		525		600
	Deposits		281		142
	Restricted cash		250		250
		$	3,256	$	3,192

Note_5_StockBased_Compensation1

Note 5 - Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
		2014					2013
					Weighted-					Weighted-
					Average					Average
					Exercise					Exercise
		Shares			Price		Shares			Price
		(In thousands except exercise price)
	Outstanding at beginning of period		4,980		$	7.01		5,209		$	6.4
	Granted		810			5.96		510			7.15
	Exercised		(4	)		6.61		(102	)		5.27
	Forfeited or expired		(81	)		7.29		(322	)		4.99
	Outstanding at period end		5,705		$	6.85		5,295		$	6.58
	Exercisable at period end		3,013		$	7		2,682		$	6.88
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	'
					Weighted-
					Average
		Number of			Grant Date
		Awards			Fair Value
	Outstanding at beginning of period		-		$	-
	Granted		276,900			5.77
	Vested		-			-
	Forfeited		-			-
	Outstanding at period end		276,900		$	5.77

Note_1_Nature_of_Business_Sign2

Note 1 - Nature of Business, Significant Accounting Policies and Recent Accounting Guidance (Details)	Mar. 31, 2014
Accounting Policies [Abstract]	'
Number of Distribution Centers	2

Note_1_Nature_of_Business_Sign3

Note 1 - Nature of Business, Significant Accounting Policies and Recent Accounting Guidance (Details) - Reconciliation of Basic Weighted-Average Shares Outstanding to Diluted Weighted-Average Shares Outstanding	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Reconciliation of Basic Weighted-Average Shares Outstanding to Diluted Weighted-Average Shares Outstanding [Abstract]	'	'
Weighted-average shares outstanding - basic	34,051	33,519
Weighted-average shares outstanding - diluted	34,051	33,519

Note_1_Nature_of_Business_Sign4

Note 1 - Nature of Business, Significant Accounting Policies and Recent Accounting Guidance (Details) - Antidilutive Securities Excluded From Calculation of Diluted Earnings Per Share	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive common stock equivalents excluded from diluted earnings per share	4,971	4,363
Equity Option [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive common stock equivalents excluded from diluted earnings per share	3,013	2,682
Warrant [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive common stock equivalents excluded from diluted earnings per share	1,681	1,681
Restricted Stock Units (RSUs) [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive common stock equivalents excluded from diluted earnings per share	277	'

Note_2_Inventory_Details_Inven

Note 2 - Inventory (Details) - Inventory (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventory [Abstract]	'	'
Bulk and other	$713	$872
Finished goods	34,940	36,271
	$35,653	$37,143

Note_3_Property_and_Equipment_1

Note 3 - Property and Equipment (Details) - Property and Equipment (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Note 3 - Property and Equipment (Details) - Property and Equipment [Line Items]	'	'
Property, Plant, and Equipment	$56,957	$57,474
Less accumulated depreciation	-28,618	-27,921
	28,339	29,553
Construction-in-progress	976	735
	29,315	30,288
Building and Building Improvements [Member]	'	'
Note 3 - Property and Equipment (Details) - Property and Equipment [Line Items]	'	'
Property, Plant, and Equipment	12,863	12,863
Furniture and Fixtures [Member]	'	'
Note 3 - Property and Equipment (Details) - Property and Equipment [Line Items]	'	'
Property, Plant, and Equipment	26,392	26,917
Computer Equipment [Member]	'	'
Note 3 - Property and Equipment (Details) - Property and Equipment [Line Items]	'	'
Property, Plant, and Equipment	4,973	5,076
Software and Software Development Costs [Member]	'	'
Note 3 - Property and Equipment (Details) - Property and Equipment [Line Items]	'	'
Property, Plant, and Equipment	9,442	9,335
Leasehold Improvements [Member]	'	'
Note 3 - Property and Equipment (Details) - Property and Equipment [Line Items]	'	'
Property, Plant, and Equipment	2,827	2,823
Land [Member]	'	'
Note 3 - Property and Equipment (Details) - Property and Equipment [Line Items]	'	'
Property, Plant, and Equipment	$460	$460

Note_4_Other_Assets_Details_Ot

Note 4 - Other Assets (Details) - Other Assets (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Other Assets [Abstract]	'	'
Goodwill	$2,200	$2,200
Intangible assets, net	525	600
Deposits	281	142
Restricted cash	250	250
	$3,256	$3,192

Note_5_StockBased_Compensation2

Note 5 - Stock-Based Compensation (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014
Employee Stock Option [Member]	'
Note 5 - Stock-Based Compensation (Details) [Line Items]	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options (in Dollars)	$7.40
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	'3 years 277 days
Restricted Stock Units (RSUs) [Member]	'
Note 5 - Stock-Based Compensation (Details) [Line Items]	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	'4 years 292 days
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	'5 years
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)	$0.90

Note_5_StockBased_Compensation3

Note 5 - Stock-Based Compensation (Details) - Stock Option Activity (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Stock Option Activity [Abstract]	'	'
Outstanding at beginning of period	4,980	5,209
Outstanding at beginning of period	$7.01	$6.40
Granted	810	510
Granted	$5.96	$7.15
Exercised	-4	-102
Exercised	$6.61	$5.27
Forfeited or expired	-81	-322
Forfeited or expired	$7.29	$4.99
Outstanding at period end	5,705	5,295
Outstanding at period end	$6.85	$6.58
Exercisable at period end	3,013	2,682
Exercisable at period end	$7	$6.88

Note_5_StockBased_Compensation4

Note 5 - Stock-Based Compensation (Details) - Summary of Restricted Stock Unit Activity (Restricted Stock Units (RSUs) [Member], USD $)	3 Months Ended
	Mar. 31, 2014
Restricted Stock Units (RSUs) [Member]	'
Note 5 - Stock-Based Compensation (Details) - Summary of Restricted Stock Unit Activity [Line Items]	'
Outstanding at beginning of period	0
Granted	276,900
Granted (in Dollars per share)	$5.77
Outstanding at period end	276,900
Outstanding at period end (in Dollars per share)	$5.77

Note_7_Income_Taxes_Details

Note 7 - Income Taxes (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'	'
Valuation Allowance, Deferred Tax Asset, Change in Amount	$1.30	'
Deferred Tax Assets, Valuation Allowance	'	$21.40